Lesson 6 of 9

Checklists and your circle of competence

Step 3 of 6

Worked example

A 15-item pre-buy checklist built from the course. Each item names the lesson to go back to if you can't answer it (6-09 means Module 6 lesson 09). Copy it into your notes.

# Check A pass looks like Lesson
1 Inside my circle? All three test questions answered 17-06, 7-01
2 Read the filings myself? Latest 10-K and 10-Q filing card done 5-08, 5-05
3 Growth and margins Several years, compared with the industry 6-01, 6-02
4 Cash vs earnings Operating cash flow tracks net income 6-07
5 Red flags None, or each one explained 6-09
6 Survives a bad year? Interest cover and liquidity checked 6-05
7 Share count Dilution measured, per-share figures used 6-08
8 Moat and returns Named source of moat; ROIC above cost of capital 7-05, 7-06
9 Management Pay and capital allocation read 7-07, 5-07
10 Industry and cycle Who takes the profit; not buying a cyclical at its peak 8-01, 8-05
11 Multiples Compared with peers, on clean earnings 9-06, 9-07
12 What the price assumes Reverse DCF written as one sentence 10-09
13 Macro What a rate rise would do to the value 11-04
14 Size and exits Size from the risk limit, under caps; sell rules written 16-03, 16-05, 16-07
15 Process Base rate checked, pre-mortem done, journal entry written 17-03, 17-05, 17-04

Add-ons, instead of items 2–9 where they don't fit:

  • A token: supply, FDV and the unlock calendar (13-01, 13-02); who owns it (13-03); whether the token captures any fees (13-04); contract, bridge and custody risk (14-05, 14-07); scam patterns (12-09).
  • A private business: SDE checked against bank statements and tax returns (15-02, 15-04); owner and customer dependence (15-04).

Running item 1 on two cases:

  • Costco. One sentence: it sells a narrow range of goods at thin margins to paying members who renew at about 90% (Module 7 lesson 01). The numbers that drive it: members, renewal rates, fees. What would break it: renewal rates falling for several years. Inside, for a learner who has done Modules 5–10 on it.
  • A drug developer whose value rests on one clinical trial. You can write the sentence but can't judge the trial's odds, the one number that decides almost everything. Outside, unless you study medicine.

Notice what has no row: liking the product, last week's price move, excitement online.